EPISODE · Jul 27, 2021 · 15 MIN
Strategies for Avoiding Adverse Reactions to BTK Inhibitor Therapy, Part 1: Drug–Drug and Drug–Food Interactions
from Decera Clinical Education Oncology Podcast · host Sandra E. Kurtin PhD ANP-C AOCN
In this podcast episode,Sandra E. Kurtin, PhD, ANP-C, AOCN, discusses nursing perspectives on avoiding adverse reactions to BTK inhibitor therapy. Topics in this first of 2 podcasts on avoiding AEs include:PharmacokineticsDrug metabolismDrug–drug interactionsDrug–food interactionsThe role of CYP enzymesFoods to avoidMedication reviewPresenter:Sandra E. Kurtin, PhD, ANP-C, AOCNDirector, Advanced Practice and Clinical IntegrationThe University of Arizona Cancer CenterAssistant Professor, Clinical MedicineAdjunct Clinical Professor, NursingThe University of ArizonaTucson, ArizonaCE/AAPA credit available by visiting the online program:https://bit.ly/3zMXFOpLink to full program, including downloadable slidesets:https://bit.ly/3iwN9Ub Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Embed this episode
What this episode covers
Listen to Sandra E. Kurtin, PhD, ANP-C, AOCN, discuss managing drug–drug and drug–food interactions to minimize adverse events in patients receiving BTK inhibitors.
Ready to play
Strategies for Avoiding Adverse Reactions to BTK Inhibitor Therapy, Part 1: Drug–Drug and Drug–Food Interactions
No transcript for this episode yet
Similar Episodes
No similar episodes found.